Clinical Trial: Increased Dietary Protein Intake During GLP-1 Medication Use (in Middle-aged Women With Overweight/Obesity)

U.S., March 19 -- ClinicalTrials.gov registry received information related to the study (NCT07480109) titled 'Increased Dietary Protein Intake During GLP-1 Medication Use (in Middle-aged Women With Overweight/Obesity)' on March 14.

Brief Summary: Middle-aged women with (overweight/)obesity who will begin or have begun GLP-1 medication use will be recruited to complete a 12-week diet intervention study. For 12-weeks, participants will continue to take their GLP-1 medication and may be provided with protein-rich foods to consume every day. Body composition, eating behavior, health, and well-being will be measured before and after the study.

Study Start Date: April 01

Study Type: INTERVENTIONAL

Condition: Obesity Women (Between 30 to 60 Y...